TARGET PharmaSolutions, a clinical data company based in Durham, has enrolled the first patient in a new observational study of how asthma patients are faring with various treatments for the disease. ...
TOULOUSE, France & LAKELAND, Mich.--(BUSINESS WIRE)--Regulatory News: Cerenis Therapeutics (Paris:CEREN) (FR0012616852 – CEREN – PEA PME eligible), an international biopharmaceutical company dedicated ...
SAN FRANCISCO--(BUSINESS WIRE)--Atomwise announced today results from the AIMS (Artificial Intelligence Molecular Screen) initiative that establish the AtomNet AI Platform as a viable alternative to ...
Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. The TARGET Study Interim Results: "Safety and Performance of the Cardiovalve Replacement ...
Salix Pharmaceuticals announced the "successful" outcome of TARGET 3, a Phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of repeat treatment with ...
Please provide your email address to receive an email when new articles are posted on . Rezpegaldesleukin is a first-in-class interleukin-2 receptor agonist that proliferates and activates regulatory ...
A new study by researchers at the University of Arizona College of Medicine – Phoenix and the University of California Davis Health identified a new target for developing a therapy to treat atrial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback